[1] D. Singh, A. Agusti, A. Anzueto, P.J. Barnes, J. Bourbeau, B.R. Celli, G.J. Criner, P. Frith, D.M. Halpin, M. Han, Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019, European Respiratory Journal 53(5) (2019) 1900164.
[2] M.R. Sears, Trends in the prevalence of asthma, Chest 145(2) (2014) 219-225.
[3] K.F. Chung, S.E. Wenzel, J.L. Brozek, A. Bush, M. Castro, P.J. Sterk, I.M. Adcock, E.D. Bateman, E.H. Bel, E.R. Bleecker, International ERS/ATS guidelines on definition, evaluation, and treatment of severe asthma, European respiratory journal 43(2) (2014) 343-373.
[4] E. Mortaz, S.D. Alipoor, M. Varahram, H. Jamaati, J. Garssen, S.E. Mumby, I.M. Adcock, Exosomes in Severe Asthma: Update in Their Roles and Potential in Therapy, BioMed research international 2018 (2018).
[5] Y. Yu, L. Wang, G. Gu, The correlation between Runx3 and bronchial asthma, Clinica Chimica Acta 487 (2018) 75-79.
[6] C.A. Oskeritzian, S. Milstien, S. Spiegel, Sphingosine-1-phosphate in allergic responses, asthma and anaphylaxis, Pharmacology & therapeutics 115(3) (2007) 390-399.
[7] F.H. QIAN, Q. Zhang, L.F. ZHOU, H. Liu, M. Huang, X.L. ZHANG, K.S. YIN, High‐sensitivity C‐reactive protein: a predicative marker in severe asthma, Respirology 13(5) (2008) 664-669.
[8] D. Galez, S. Dodig, M. Raos, B. Nogalo, C-reactive protein in children with asthma and allergic rhinitis, Biochemia Medica 16(2) (2006) 163-169.
[9] M. Monadi, A. Firouzjahi, A. Hosseini, Y. Javadian, M. Sharbatdaran, B. Heidari, Serum C-reactive protein in asthma and its ability in predicting asthma control, a case-control study, Caspian journal of internal medicine 7(1) (2016) 37.
[10] S. Mohammed, K. Harikumar, Sphingosine 1-phosphate: a novel target for lung disorders, Frontiers in immunology 8 (2017) 296.
[11] H.K.T. Trinh, S.-C. Kim, K. Cho, S.-J. Kim, G.-Y. Ban, H.-J. Yoo, J.-Y. Cho, H.-S. Park, S.-H. Kim, Exploration of the sphingolipid metabolite, sphingosine-1-phosphate and sphingosine, as novel biomarkers for aspirin-exacerbated respiratory disease, Scientific reports 6 (2016) 36599.
[12] H. Ikeda, R. Ohkawa, N. Watanabe, K. Nakamura, Y. Kume, H. Nakagawa, H. Yoshida, S. Okubo, H. Yokota, T. Tomiya, Plasma concentration of bioactive lipid mediator sphingosine 1-phosphate is reduced in patients with chronic hepatitis C, Clinica chimica acta 411(9-10) (2010) 765-770.
[13] R.P.L. Panganiban, M.H. Pinkerton, S.Y. Maru, S.J. Jefferson, A.N. Roff, F.T. Ishmael, Differential microRNA epression in asthma and the role of miR-1248 in regulation of IL-5, American journal of clinical and experimental immunology 1(2) (2012) 154.
[14] F. van der Sijde, E.E. Vietsch, D.A. Mustafa, Y. Li, C.H. van Eijck, Serum miR-338-3p and miR-199b-5p are associated with the absolute neutrophil count in patients with resectable pancreatic cancer, Clinica Chimica Acta (2020).
[15] Y. Zhao, Z. Ling, Y. Hao, X. Pang, X. Han, J.A. Califano, L. Shan, X. Gu, MiR-124 acts as a tumor suppressor by inhibiting the expression of sphingosine kinase 1 and its downstream signaling in head and neck squamous cell carcinoma, Oncotarget 8(15) (2017) 25005.
[16] J. Xia, Z. Wu, C. Yu, W. He, H. Zheng, Y. He, W. Jian, L. Chen, L. Zhang, W. Li, miR‐124 inhibits cell proliferation in gastric cancer through down‐regulation of SPHK1, The Journal of pathology 227(4) (2012) 470-480.
[17] Q. Li, Z. Pan, X. Wang, Z. Gao, C. Ren, W. Yang, miR-125b-1-3p inhibits trophoblast cell invasion by targeting sphingosine-1-phosphate receptor 1 in preeclampsia, Biochemical and biophysical research communications 453(1) (2014) 57-63.
[18] N. Cheng, G.H. Wang, miR-133b, a microRNA targeting S1PR1, suppresses nasopharyngeal carcinoma cell proliferation, Experimental and therapeutic medicine 11(4) (2016) 1469-1474.
[19] A. Fan, Q. Wang, Y. Yuan, J. Cheng, L. Chen, X. Guo, Q. Li, B. Chen, X. Huang, Q. Huang, Liver X receptor-α and miR-130a-3p regulate expression of sphingosine 1-phosphate receptor 2 in human umbilical vein endothelial cells, American Journal of Physiology-Cell Physiology 310(3) (2015) C216-C226.
[20] W. Yang, A. Wang, C. Zhao, Q. Li, Z. Pan, X. Han, C. Zhang, G. Wang, C. Ji, G. Wang, miR-125b enhances IL-8 production in early-onset severe preeclampsia by targeting sphingosine-1-phosphate lyase 1, PloS one 11(12) (2016) e0166940.
[21] X. Liu, B. Pan, L. Sun, X. Chen, K. Zeng, X. Hu, T. Xu, M. Xu, S. Wang, Circulating exosomal miR-27a and miR-130a act as novel diagnostic and prognostic biomarkers of colorectal cancer, Cancer Epidemiology and Prevention Biomarkers 27(7) (2018) 746-754.
[22] H. Xin, Y. Li, B. Buller, M. Katakowski, Y. Zhang, X. Wang, X. Shang, Z.G. Zhang, M. Chopp, Exosome‐mediated transfer of miR‐133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth, Stem cells 30(7) (2012) 1556-1564.
[23] J. Yang, X. Zhang, X. Chen, L. Wang, G. Yang, Exosome mediated delivery of miR-124 promotes neurogenesis after ischemia, Molecular Therapy-Nucleic Acids 7 (2017) 278-287.
[24] E. Alegre, M.F. Sanmamed, C. Rodriguez, O. Carranza, S. Martín-Algarra, Á. González, Study of circulating microRNA-125b levels in serum exosomes in advanced melanoma, Archives of Pathology and Laboratory Medicine 138(6) (2014) 828-832.
[25] S.L. Li, N. An, B. Liu, S.Y. Wang, J.J. Wang, Y. Ye, Exosomes from LNCaP cells promote osteoblast activity through miR‑375 transfer, Oncology letters 17(5) (2019) 4463-4473.
[26] S.D. Alipoor, E. Mortaz, P. Tabarsi, P. Farnia, M. Mirsaeidi, J. Garssen, M. Movassaghi, I.M. Adcock, Bovis Bacillus Calmette–Guerin (BCG) infection induces exosomal miRNA release by human macrophages, Journal of translational medicine 15(1) (2017) 105.
[27] B. Levänen, N.R. Bhakta, P.T. Paredes, R. Barbeau, S. Hiltbrunner, J.L. Pollack, C.M. Sköld, M. Svartengren, J. Grunewald, S. Gabrielsson, Altered microRNA profiles in bronchoalveolar lavage fluid exosomes in asthmatic patients, Journal of Allergy and Clinical Immunology 131(3) (2013) 894-903. e8.
[28] P. Torregrosa Paredes, J. Esser, C. Admyre, M. Nord, Q. Rahman, A. Lukic, O. Rådmark, R. Grönneberg, J. Grunewald, A. Eklund, Bronchoalveolar lavage fluid exosomes contribute to cytokine and leukotriene production in allergic asthma, Allergy 67(7) (2012) 911-919.
[29] F. Fatemi, E. Sadroddiny, A. Gheibi, T. Mohammadi Farsani, G.A. Kardar, Biomolecular markers in assessment and treatment of asthma, Respirology 19(4) (2014) 514-523.
[30] K. Matsunaga, S. Yanagisawa, T. Ichikawa, K. Ueshima, K. Akamatsu, T. Hirano, M. Nakanishi, T. Yamagata, Y. Minakata, M. Ichinose, Airway cytokine expression measured by means of protein array in exhaled breath condensate: correlation with physiologic properties in asthmatic patients, Journal of Allergy and Clinical Immunology 118(1) (2006) 84-90.
[31] J.S. Schorey, C.V. Harding, Extracellular vesicles and infectious diseases: new complexity to an old story, The Journal of clinical investigation 126(4) (2016) 1181-1189.
[32] P. Reclusa, S. Taverna, M. Pucci, E. Durendez, S. Calabuig, P. Manca, M.J. Serrano, L. Sober, P. Pauwels, A. Russo, Exosomes as diagnostic and predictive biomarkers in lung cancer, Journal of thoracic disease 9(Suppl 13) (2017) S1373.
[33] R.P. Panganiban, Y. Wang, J. Howrylak, V.M. Chinchilli, T.J. Craig, A. August, F.T. Ishmael, Circulating microRNAs as biomarkers in patients with allergic rhinitis and asthma, Journal of Allergy and Clinical Immunology 137(5) (2016) 1423-1432.
[34] H.K. Reddel, J.M. FitzGerald, E.D. Bateman, L.B. Bacharier, A. Becker, G. Brusselle, R. Buhl, A.A. Cruz, L. Fleming, H. Inoue, GINA 2019: a fundamental change in asthma management: Treatment of asthma with short-acting bronchodilators alone is no longer recommended for adults and adolescents, Eur Respiratory Soc, 2019.
[35] M.R. Fernando, C. Jiang, G.D. Krzyzanowski, W.L. Ryan, New evidence that a large proportion of human blood plasma cell-free DNA is localized in exosomes, PLoS One 12(8) (2017) e0183915.
[36] F. Dati, K. Ringel, Reference values for serum IgE in healthy non-atopic children and adults, Clinical chemistry, AMER ASSOC CLINICAL CHEMISTRY 2101 L STREET NW, SUITE 202, WASHINGTON, DC …, 1982, pp. 1556-1556.
[37] C.P. Price, A.K. Trull, D. Berry, E.G. Gorman, Development and validation of a particle-enhanced turbidimetric immunoassay for C-reactive protein, Journal of immunological methods 99(2) (1987) 205-211.
[38] S. Eda, J. Kaufmann, W. Roos, S. Pohl, Development of a new microparticle‐enhanced turbidimetric assay for C‐reactive protein with superior features in analytical sensitivity and dynamic range, Journal of clinical laboratory analysis 12(3) (1998) 137-144.
[39] C. Théry, S. Amigorena, G. Raposo, A. Clayton, Isolation and characterization of exosomes from cell culture supernatants and biological fluids, Current protocols in cell biology 30(1) (2006) 3.22. 1-3.22. 29.
[40] S.D. Alipoor, P. Tabarsi, M. Varahram, M. Movassaghi, M.K. Dizaji, G. Folkerts, J. Garssen, I.M. Adcock, E. Mortaz, Serum exosomal miRNAs are associated with active pulmonary tuberculosis, Disease markers 2019 (2019).
[41] N. Karami, S.H. Mirabutalebi, F. Montazeri, S.M. Kalantar, M.H. Sheikhha, M. Eftekhar, Aberrant expression of microRNAs 16 and 21 and gene targets in women with unexplained recurrent miscarriage: A case-control study, International Journal of Reproductive BioMedicine 16(10) (2018) 617.
[42] K.J. Livak, T.D. Schmittgen, Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method, methods 25(4) (2001) 402-408.
[43] S. Valmiki, V. Ahuja, N. Puri, J. Paul, miR-125b and miR-223 Contribute to Inflammation by Targeting the Key Molecules of NFκB Pathway, Frontiers in Medicine 6 (2019).
[44] Y. Zhang, B. Hou, C. Li, H. Li, Overexpression of circARF3 mitigates TNF-α-induced inflammatory damage by up-regulating miR-125b, Cell Cycle 19(11) (2020) 1253-1264.
[45] S. Taka, P. Tzani-Tzanopoulou, H. Wanstall, N.G. Papadopoulos, MicroRNAs in asthma and respiratory infections: identifying common pathways, Allergy, asthma & immunology research 12(1) (2020) 4-23.
[46] A. Fan, Q. Wang, Y. Yuan, J. Cheng, L. Chen, X. Guo, Q. Li, B. Chen, X. Huang, Q. Huang, Liver X receptor-α and miR-130a-3p regulate expression of sphingosine 1-phosphate receptor 2 in human umbilical vein endothelial cells, American Journal of Physiology-Cell Physiology 310(3) (2016) C216-C226.
[47] A.V. Nguyen, Y.-Y. Wu, E.Y. Lin, STAT3 and sphingosine-1-phosphate in inflammation-associated colorectal cancer, World journal of gastroenterology 20(30) (2014) 10279.